Home » All » Stock Forecast » Aktis Oncology Inc. Common stock Forecast

Aktis Oncology Inc. Common stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC
▼ -1.58%Market Cap $1.13B · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

TimeframePredicted PricePastHistoricalInsight
Tomorrow$20.32 -0.88%Yesterday$20.58 +0.37%Tomorrow's Aktis Oncology Inc. Common stock (AKTS) setup is anchored to $20.50 and targets $20.32 (-0.88%). The near-term read is downside; watch $21.12 / $19.88 because daily realized volatility is about 4.56%.
Tomorrow's Aktis Oncology Inc. Common stock (AKTS) setup is anchored to $20.50 and targets $20.32 (-0.88%). The near-term read is downside; watch $21.12 / $19.88 because daily realized volatility is about 4.56%.
Week$19.94 -2.75%Last Week$20.74 +1.16%The 7-day Aktis Oncology Inc. Common stock model moves from $20.74 to $19.94 (-2.75%). It gives downside momentum context for this stock, so breaks around $21.12 / $19.88 matter more than a single tick.
The 7-day Aktis Oncology Inc. Common stock model moves from $20.74 to $19.94 (-2.75%). It gives downside momentum context for this stock, so breaks around $21.12 / $19.88 matter more than a single tick.
Month$19.30 -5.86%Last Month$21.00 +2.46%The 1-month Aktis Oncology Inc. Common stock target is $19.30 (-5.86%), compared with the live reference near $20.50. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Aktis Oncology Inc. Common stock target is $19.30 (-5.86%), compared with the live reference near $20.50. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$18.34 -10.51%Last Year$21.41 +4.42%The 1-year Aktis Oncology Inc. Common stock scenario points to $18.34 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Aktis Oncology Inc. Common stock scenario points to $18.34 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$16.11 -21.43%5 Years Ago$22.35 +9.00%The 5-year Aktis Oncology Inc. Common stock view is $16.11 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Aktis Oncology Inc. Common stock view is $16.11 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Tomorrow$20.32 -0.88%
Yesterday$20.58 +0.37%
Tomorrow's Aktis Oncology Inc. Common stock (AKTS) setup is anchored to $20.50 and targets $20.32 (-0.88%). The near-term read is downside; watch $21.12 / $19.88 because daily realized volatility is about 4.56%.
Week$19.94 -2.75%
Last Week$20.74 +1.16%
The 7-day Aktis Oncology Inc. Common stock model moves from $20.74 to $19.94 (-2.75%). It gives downside momentum context for this stock, so breaks around $21.12 / $19.88 matter more than a single tick.
Month$19.30 -5.86%
Last Month$21.00 +2.46%
The 1-month Aktis Oncology Inc. Common stock target is $19.30 (-5.86%), compared with the live reference near $20.50. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$18.34 -10.51%
Last Year$21.41 +4.42%
The 1-year Aktis Oncology Inc. Common stock scenario points to $18.34 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$16.11 -21.43%
5 Years Ago$22.35 +9.00%
The 5-year Aktis Oncology Inc. Common stock view is $16.11 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish
$21.07$20.69$20.31$19.92$19.541W AgoNow7D F

Technical Analysis

SellNeutralBuy
Bearish
0
Bullish
3
Neutral
2
Bearish

Key Indicators

IndicatorValueSignal
Price$20.50 Mid
Daily Change-1.58% Below
Volatility Cap20.0% Mid
Confidence60% Below
Data Sourcenasdaq-screener Mid

Historical Data

Current$20.50
Daily Change-1.58%
Market Cap$1.13B
Sourcenasdaq-screener
Current$20.50Daily Change-1.58%
Market Cap$1.13BSourcenasdaq-screener

Support & Resistance Levels

$19.88Support 1
$20.50Current
$21.12Resistance 1
i
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context
Current$20.50Live reference price
Used as the anchor for generated forecast calculations.
Next Month$19.30Model projection-5.86%
Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed
60%
Directional
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.
Short term
60%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in AKTS today
Bullish Scenario
$21.53
+5.00% from current
Target Price$21.53
ScenarioUpside momentum
Probability52%
Base Scenario
$19.30
-5.86%
Target Price$19.30
ScenarioCapped drift
Probability60%
Bearish Scenario
$19.47
-5.00% from current
Target Price$19.47
ScenarioVolatility drawdown
Probability40%
Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bearish · 38/100
24H drift-0.88%
7D drift-2.75%
30D drift-5.86%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-Off Caution · 31/100
1M outlook-5.86%
1Y outlook-10.51%
5Y outlook-21.43%

Frequently Asked Questions

Q What is the Aktis Oncology Inc. Common stock (AKTS) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Aktis Oncology Inc. Common stock is projected near $20.32 versus the current reference around $20.50. That implies a modeled move of -0.88% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for AKTS?
The weekly Aktis Oncology Inc. Common stock model points to $19.94, which maps to an expected drift of -2.75% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Aktis Oncology Inc. Common stock 1-month and 1-year targets?
The Aktis Oncology Inc. Common stock 1-month target is $19.30 (-5.86%), while the 1-year target is $18.34 (-10.51%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Aktis Oncology Inc. Common stock 5-year scenario differ from short-term rows?
The Aktis Oncology Inc. Common stock long-horizon scenario sits near $16.11 with a modeled change of -21.43%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are AKTS support and resistance zones right now?
For Aktis Oncology Inc. Common stock, nearest resistance is around $19.88, while nearest support is around $21.12. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Aktis Oncology Inc. Common stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.
Aktis Oncology Inc. Common stock Forecast 2026 – Tomorrow, Week & Month